Personalized Medicine for ASD
Our approach has expanded to analyze proteomic biomarkers as a way to identify ASD in younger children. Cell-El researchers envision
Our approach has expanded to analyze proteomic biomarkers as a way to identify ASD in younger children. Cell-El researchers envision
Cell-El researchers chose to broaden our biomarker analysis from 2–12 year-olds undergoing Stem Cell Therapy (SCT) to include children and
This article presents the rationale behind stem cell-based treatment for autism patients due to immune and nervous system abnormalities. This
Cell El Ltd. has been studying the effects of stem cell treatment (SCT) on biomarkers in children with ASD ages
First of all, one can’t truly research a medical treatment for Autism without understanding the medical condition - what it
Cell-El is pleased to announce that we are opening up recruitment for a new group of children in our study:
In the research article “Therapeutic properties of mesenchymal stem cells for autism spectrum disorders” published in Medical Hypotheses, Dr. Beni
In Israeli news and media outlets, Ms. Hanna Abramovich of Israel has shared the amazing progress in her son Avi.
Today, Shira and Haggai Reiner share with Cell-El Ltd their first-hand experience with Stem Cell Therapy for their son Dolev.
Cell-El, Ltd. is specifically focused on rectifying the state of SCT clinical research for ASD. We too believe that further